What is the effect of cannabis on Attention Deficit Hyperactivity Disorder (ADHD) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cannabis Use in ADHD: Not Recommended and Potentially Harmful

Cannabis is not recommended for people with ADHD as it may worsen symptoms and carries significant risks, particularly for adolescents and young adults with developing brains. 1

Evidence Against Cannabis Use in ADHD

Lack of Clinical Evidence

  • The American Academy of Pediatrics explicitly states that "the suggestion that cannabidiol oil has any effect on ADHD is anecdotal and has not been subjected to rigorous study" 2
  • Only one randomized controlled trial has directly measured cannabis effects on ADHD, finding no significant improvement in the primary outcome 1
  • Most studies indicate cannabis either worsens ADHD symptoms or has no beneficial effect 1

Risks for ADHD Patients

  • Cannabis use during adolescence contributes to structural and functional brain changes associated with:

    • Deficits in episodic memory, decision making, attention, and processing speed 2
    • Altered prefrontal cortex connectivity and increased risk for psychopathology 2
    • Altered grey matter volume and cortical thickness 2

  • These neurological effects are particularly concerning for ADHD patients who already struggle with executive function

Specific Concerns for Youth with ADHD

  • ADHD is a risk factor for problematic cannabis use 3
  • Adolescents with ADHD have higher rates of cannabis use than the general population 4
  • Early cannabis initiation (before age 16) may be linked to poorer executive functioning outcomes 5

Recommended Evidence-Based ADHD Treatments

First-Line Treatments

  1. FDA-approved medications (Grade A strong recommendation) 2

    • Stimulant medications (methylphenidate, amphetamine)
    • Non-stimulants (atomoxetine, extended-release guanfacine, extended-release clonidine)

  2. Evidence-based behavioral interventions (Grade A strong recommendation) 2

    • Behavioral therapy
    • Training interventions targeting organization and time management
    • Educational interventions and individualized instructional supports

Combined Approach

  • Combination of medication management and behavioral therapy allows for lower stimulant dosages, potentially reducing adverse effects 2
  • Parents and teachers report higher satisfaction with combined treatment approaches 2

Special Considerations for Cannabis Use in ADHD Patients

Assessment and Monitoring

  • Clinicians should assess for substance use when initiating ADHD treatment 2
  • If active substance use is identified, referral to a specialist is recommended 2
  • Consider non-stimulant medications (atomoxetine, extended-release guanfacine, extended-release clonidine) for patients with substance use concerns 2

Addressing Patient Perceptions

  • Despite lack of evidence, online discussions indicate that cannabis is increasingly perceived as therapeutic for ADHD 3
  • 25% of posts in online forums endorse cannabis as therapeutic for ADHD versus only 8% indicating harm 3
  • Clinicians should be prepared to address these misconceptions with evidence-based information

Risks of Cannabis Use

General Health Risks

  • Cannabis use is associated with:
    • Increased risk for developing depressive disorders 2
    • Potential exacerbation of psychiatric disorders 2
    • Risk of cannabis use disorder (10% of chronic users) 2
    • Impaired driving ability and increased risk of motor vehicle accidents 2

Specific Risks for Adolescents

  • Cannabis may have deleterious effects on adolescent brain development 2
  • Early youth cannabis use is associated with:
    • Neuropsychological and neurodevelopmental decline
    • Elevated risk for psychotic disorders in adulthood
    • Higher risk for depression and suicidal ideation 2

Conclusion

The evidence strongly suggests avoiding cannabis use for ADHD management. Instead, FDA-approved medications and evidence-based behavioral interventions remain the standard of care with proven efficacy and safety profiles. Clinicians should be vigilant about cannabis use in ADHD patients and provide education about its potential harms, particularly for adolescents and young adults.

References

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How to manage ADHD and emotional control issues while using marijuana after stopping Vyvanse (lisdexamfetamine)?
How should patients taking stimulants for Attention Deficit Hyperactivity Disorder (ADHD) be counseled on the use of caffeine, alcohol, and cannabis?
How can I manage a patient with ADHD who is adhering to their stimulant medication regimen, as confirmed by urine analysis (UA), but is also using cannabis, in a practice with a no-tolerance policy for illegal substances?
Why should marijuana (THC) be used with Attention Deficit Hyperactivity Disorder (ADHD) medication, such as Ritalin (methylphenidate) or Adderall (amphetamine and dextroamphetamine)?
Is it safe to use marijuana while taking Strattera (atomoxetine) for Attention Deficit Hyperactivity Disorder (ADHD)?
What are the indications for Z-plasty (Z-plastic surgery)?
What is the recommended treatment approach for a patient with a pituitary adenoma and positive high-dose dexamethasone (DXM) suppression test?
How is Temporomandibular Joint (TMJ) disorder improved?
Should folic acid be taken with weekly methotrexate (MTX) for Rheumatoid Arthritis (RA)?
What is the immediate treatment for hypoglycemia (low blood sugar) in an 8-year-old child?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question